Hints and tips:
Related Special Reports
...Gilead has worked with scientists at Accelerated Clinical Trials Ltd to develop a blood cancer treatment....
...Also attracting investors is Shanghai-based Fu Shou Yuan International, China’s biggest funeral services provider and seller of burial plots....
...Gilead SciencesO: 6; L: 8; I: 7; Total: 21The South Korean legal team at the US-based pharma group increased self-service on legal issues in the rest of the business....
...China has pledged Covid vaccines across the developing world but the international rollout has been hampered by lingering concerns about its efficacy, as Chinese manufacturers have been slower than western...
...A key differentiating factor between these groups and Fosun issubsidiary Fosun Pharma....
...Late last year, pharma group Merck succeeded in a US court claim that a war exclusion should not be applied to its losses suffered in the NotPetya malware attack....
...International co-operation is desperately needed to solve this market failure....
...The German drugmaker has sought to enter the Chinese market through a distribution partnership with China’s Fosun Pharma....
...Teva separately received a boost on Tuesday when the company, along with Johnson & Johnson, Endo International, and Allergan, won a case related to the US opioid addiction crisis....
...“We have developed vaccines against [the] Delta and Beta variants,” Zhu told Chinese state media at the China International Fair for Trade in Services in Beijing....
...Two huge deals were announced on Thursday alone: in the US, medical technology group Baxter International took over its rival Hillrom for $12.4bn, and in Europe, private equity firm Advent International...
...“I’m not seeing the pandemic as a huge recurring opportunity for pharma in general,” said Nithya Balasubramanian, a pharma analyst at Sanford Bernstein....
...Fosun Pharma, the Hong Kong and Shanghai-listed healthcare unit of conglomerate Fosun International, became the Chinese partner of BioNTech in March, pledging $135m towards developing a Covid-19 vaccine...
...HSBC Sector: BANKS / HQ: LONDON, uk HSBC executives are fond of the quip that it is “the biggest international bank in China, as well as the most international Chinese bank”....
...The lack of transparency over data and regulatory approval for Chinese vaccines has caused international experts to question whether global standards are being met....
...The company needs to produce and deliver the jab — a process that has proved fraught for most pharma groups....
...“London has to get that playbook out from 1980-85,” said Richard Gnodde, head of Goldman Sachs’ international arm....
...Moelis & Company has hired Elan Zivotofsky as a managing director in Tel Aviv. He joins from Ibex Investors....
...Judith Finegold, a portfolio manager at Fidelity International, added that treatments for the virus “cannot be achieved by one company or country alone.”...
...The race to produce a coronavirus vaccine accelerated on Monday when the German group BioNTech announced a $135m partnership with Fosun Pharma of China to develop a Covid-19 vaccine, which it said could...
...It is the second time JPMorgan has found itself on it, following a due diligence-related problem connected to the 2016 application of Shenhua Health Holdings, a pharma company....
...But the Hong Kong board has more liquidity, while frequency of international collaboration in biotech means Chinese companies often prefer to raise money in Hong Kong dollars, which, unlike the renminbi,...
...Mr Hellebo said this partly reflected the typical pharma development cycle....
...Separately, Merck, the US pharma group, announced results from an early trial for a new treatment for HIV at the conference....
...It has continued to make acquisitions, completing a $1.1bn deal for India’s Gland Pharma, followed by a €120m controlling stake in Lanvin, France’s oldest couturier, last year....
International Edition